|
World Heart Corporation - Company Profile Snapshot
| Company Profile: |
World Heart Corporation |
| Ticker: |
WHT |
| Exchanges: |
NAS TOR |
| 2007 Sales: |
2,735,100 |
| Major Industry: |
Drugs, Cosmetics & Health Care |
| Sub Industry: |
Medical, Surgical & Dental Suppliers |
| Country: |
CANADA |
| Employees: |
55 |
Business Description
World Heart Corporation. The Group's principal activity is to develop artificial heart technologies. The Group is focused on two technologies: Novacor LVAS and the HeartSaver Ventricular Assist Device (HeartSaver). Novacor technology is currently in commercial production and the HeartSaver technology is currently under development. This technology is being developed from licensed artificial heart and related technologies developed by the Cardiovascular Devices Division (CVD) of the Ottawa Heart Institute Research Corporation. The Group operates in Canada and the United States.
|
Not the Report you are looking for?
Click here for more browsing options.
|
The following information is available to subscribers or can be accessed by purchasing the Company Profile Report:
|
- Address (mailing), Phone Number, Web Address
- Earnings/Dividends
- Employees
- Exchanges Listed
- Financial Ratio Analysis |
- Recent Stock Performance
- Sales (recent year)
- Senior Officers
- Shareholder Information
- Stock Analysis Summary |
Layout and Content of a Typical Report
|
|
|
|
|
